BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 14973998)

  • 1. Treatment for lupus nephritis.
    Flanc RS; Roberts MA; Strippoli GF; Chadban SJ; Kerr PG; Atkins RC
    Cochrane Database Syst Rev; 2004; (1):CD002922. PubMed ID: 14973998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials.
    Flanc RS; Roberts MA; Strippoli GF; Chadban SJ; Kerr PG; Atkins RC
    Am J Kidney Dis; 2004 Feb; 43(2):197-208. PubMed ID: 14750085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for lupus nephritis.
    Henderson L; Masson P; Craig JC; Flanc RS; Roberts MA; Strippoli GF; Webster AC
    Cochrane Database Syst Rev; 2012 Dec; 12():CD002922. PubMed ID: 23235592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive treatment for proliferative lupus nephritis.
    Tunnicliffe DJ; Palmer SC; Henderson L; Masson P; Craig JC; Tong A; Singh-Grewal D; Flanc RS; Roberts MA; Webster AC; Strippoli GF
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002922. PubMed ID: 29957821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials.
    Henderson LK; Masson P; Craig JC; Roberts MA; Flanc RS; Strippoli GF; Webster AC
    Am J Kidney Dis; 2013 Jan; 61(1):74-87. PubMed ID: 23182601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2010 Nov; (11):CD003594. PubMed ID: 21069676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive agents for treating IgA nephropathy.
    Samuels JA; Strippoli GF; Craig JC; Schena FP; Molony DA
    Cochrane Database Syst Rev; 2003; (4):CD003965. PubMed ID: 14584001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM; Wong SC; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD003594. PubMed ID: 27726125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-corticosteroid treatment for nephrotic syndrome in children.
    Durkan A; Hodson E; Willis N; Craig J
    Cochrane Database Syst Rev; 2001; (4):CD002290. PubMed ID: 11687155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Habashy D; Hodson E; Craig J
    Cochrane Database Syst Rev; 2004; (2):CD003594. PubMed ID: 15106208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drugs (NSAIDs) versus opioids for acute renal colic.
    Holdgate A; Pollock T
    Cochrane Database Syst Rev; 2004; (1):CD004137. PubMed ID: 14974058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM; Habashy D; Craig JC
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003594. PubMed ID: 16625586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multitarget therapy versus intravenous cyclophosphamide in the induction treatment of lupus nephritis: a metaanalysis of randomized controlled trials.
    Deng J; Luo L; Zhu L; Xie H; xie H
    Turk J Med Sci; 2018 Oct; 48(5):901-910. PubMed ID: 30384552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-corticosteroid treatment for nephrotic syndrome in children.
    Hodson EM; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2008 Jan; (1):CD002290. PubMed ID: 18254005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis.
    Feng L; Deng J; Huo DM; Wu QY; Liao YH
    Nephrology (Carlton); 2013 Feb; 18(2):104-10. PubMed ID: 23113811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
    Pravitsitthikul N; Willis NS; Hodson EM; Craig JC
    Cochrane Database Syst Rev; 2013 Oct; (10):CD002290. PubMed ID: 24166716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
    Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
    Zhu B; Chen N; Lin Y; Ren H; Zhang W; Wang W; Pan X; Yu H
    Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for renal vasculitis in adults.
    Walters G; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2015 Sep; (9):CD003232. PubMed ID: 26400765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.